Descriptor English: | Bexarotene | ||||||
Descriptor Spanish: |
Bexaroteno
| ||||||
Descriptor Portuguese: | Bexaroteno | ||||||
Descriptor French: | Bexarotène | ||||||
Entry term(s): |
3-methyl-TTNEB 4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid LG69 compound LGD 1069 LGD-1069 LGD1069 Targretin |
||||||
Tree number(s): |
D02.455.426.559.847.638.960.423 D04.615.638.960.423 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077610 | ||||||
Scope note: | A rexinoid (an RXR-binding ligand), tetrahydronaphthalene derivative and RETINOID X RECEPTOR antagonist that is used in the treatment of CUTANEOUS T-CELL LYMPHOMA. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents |
||||||
Registry Number: | A61RXM4375 | ||||||
Public MeSH Note: | 2019; BEXAROTENE was indexed under TETRAHYDRONAPHTHALENES 1995-2018 |
||||||
History Note: | 2019 (1995) |
||||||
DeCS ID: | 57713 | ||||||
Unique ID: | D000077610 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2020/06/09 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Bexarotene
- Preferred
LG69 compound
- Narrower
LGD 1069
- Narrower
Targretin
- Narrower
Concept UI |
M0250478 |
Scope note | A rexinoid (an RXR-binding ligand), tetrahydronaphthalene derivative and RETINOID X RECEPTOR antagonist that is used in the treatment of CUTANEOUS T-CELL LYMPHOMA. |
Preferred term | Bexarotene |
Entry term(s) |
3-methyl-TTNEB 4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid |
Concept UI |
M0250479 |
Preferred term | LG69 compound |
Concept UI |
M0250483 |
Preferred term | LGD 1069 |
Entry term(s) |
LGD-1069 LGD1069 |
Concept UI |
M0250482 |
Preferred term | Targretin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey